Global Nuclear Medicine Market Research Report 2022(Status and Outlook)

June 2022 | 114 pages | ID: G1A9F611621DEN
Bosson Research

Abstracts

Report Overview

Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The Global Nuclear Medicine Market Size was estimated at USD 6196.01 million in 2021 and is projected to reach USD 10262.09 million by 2028, exhibiting a CAGR of 7.47% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Nuclear Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine market in any manner.

Global Nuclear Medicine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• GE Healthcare
• Bracco Imaging
• Mallinckrodt
• Lantheus Medical Imaging
• Bayer
• Triad Isotopes
• Nordion
• Jubilant Pharma
• Eli Lilly
• SIEMENS
• China Isotope and Radiation
• Dongcheng

Market Segmentation (by Type)

• Tc-99
• I-123/131
• In-111
• Xe-133
• Th-201
• Ga-67
• Others

Market Segmentation (by Application)

• Diagnostic
• Therapeutic

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Nuclear Medicine Market
• Overview of the regional outlook of the Nuclear Medicine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Nuclear Medicine
1.2 Key Market Segments
  1.2.1 Nuclear Medicine Segment by Type
  1.2.2 Nuclear Medicine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 NUCLEAR MEDICINE MARKET OVERVIEW

2.1 Global Nuclear Medicine Market Size (M USD) Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 NUCLEAR MEDICINE MARKET COMPETITIVE LANDSCAPE

3.1 Global Nuclear Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2 Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturers Nuclear Medicine Sales Sites, Area Served, Service Type
3.4 Nuclear Medicine Market Competitive Situation and Trends
  3.4.1 Nuclear Medicine Market Concentration Rate
  3.4.2 Global 5 and 10 Largest Nuclear Medicine Players Market Share by Revenue
  3.4.3 Mergers & Acquisitions, Expansion

4 NUCLEAR MEDICINE VALUE CHAIN ANALYSIS

4.1 Nuclear Medicine Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 Mergers & Acquisitions
  5.5.2 Expansions
  5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies

6 NUCLEAR MEDICINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Market Size Market Share by Type (2017-2022)
6.3 Global Nuclear Medicine Sales Growth Rate by Type (2017-2022)

7 NUCLEAR MEDICINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Market Size (M USD) by Application (2017-2022)
7.3 Global Nuclear Medicine Sales Growth Rate by Application (2017-2022)

8 NUCLEAR MEDICINE MARKET SEGMENTATION BY REGION

8.1 Global Nuclear Medicine Market Size by Region
  8.1.1 Global Nuclear Medicine Market Size by Region
  8.1.2 Global Nuclear Medicine Market Share by Region
8.2 North America
  8.2.1 North America Nuclear Medicine Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Nuclear Medicine Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Nuclear Medicine Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Nuclear Medicine Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Nuclear Medicine Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 GE Healthcare
  9.1.1 GE Healthcare Nuclear Medicine Basic Information
  9.1.2 GE Healthcare Nuclear Medicine Product Overview
  9.1.3 GE Healthcare Nuclear Medicine Product Market Performance
  9.1.4 GE Healthcare Business Overview
  9.1.5 GE Healthcare Nuclear Medicine SWOT Analysis
  9.1.6 GE Healthcare Recent Developments
9.2 Bracco Imaging
  9.2.1 Bracco Imaging Nuclear Medicine Basic Information
  9.2.2 Bracco Imaging Nuclear Medicine Product Overview
  9.2.3 Bracco Imaging Nuclear Medicine Product Market Performance
  9.2.4 Bracco Imaging Business Overview
  9.2.5 Bracco Imaging Nuclear Medicine SWOT Analysis
  9.2.6 Bracco Imaging Recent Developments
9.3 Mallinckrodt
  9.3.1 Mallinckrodt Nuclear Medicine Basic Information
  9.3.2 Mallinckrodt Nuclear Medicine Product Overview
  9.3.3 Mallinckrodt Nuclear Medicine Product Market Performance
  9.3.4 Mallinckrodt Business Overview
  9.3.5 Mallinckrodt Nuclear Medicine SWOT Analysis
  9.3.6 Mallinckrodt Recent Developments
9.4 Lantheus Medical Imaging
  9.4.1 Lantheus Medical Imaging Nuclear Medicine Basic Information
  9.4.2 Lantheus Medical Imaging Nuclear Medicine Product Overview
  9.4.3 Lantheus Medical Imaging Nuclear Medicine Product Market Performance
  9.4.4 Lantheus Medical Imaging Business Overview
  9.4.5 Lantheus Medical Imaging Nuclear Medicine SWOT Analysis
  9.4.6 Lantheus Medical Imaging Recent Developments
9.5 Bayer
  9.5.1 Bayer Nuclear Medicine Basic Information
  9.5.2 Bayer Nuclear Medicine Product Overview
  9.5.3 Bayer Nuclear Medicine Product Market Performance
  9.5.4 Bayer Business Overview
  9.5.5 Bayer Nuclear Medicine SWOT Analysis
  9.5.6 Bayer Recent Developments
9.6 Triad Isotopes
  9.6.1 Triad Isotopes Nuclear Medicine Basic Information
  9.6.2 Triad Isotopes Nuclear Medicine Product Overview
  9.6.3 Triad Isotopes Nuclear Medicine Product Market Performance
  9.6.4 Triad Isotopes Business Overview
  9.6.5 Triad Isotopes Recent Developments
9.7 Nordion
  9.7.1 Nordion Nuclear Medicine Basic Information
  9.7.2 Nordion Nuclear Medicine Product Overview
  9.7.3 Nordion Nuclear Medicine Product Market Performance
  9.7.4 Nordion Business Overview
  9.7.5 Nordion Recent Developments
9.8 Jubilant Pharma
  9.8.1 Jubilant Pharma Nuclear Medicine Basic Information
  9.8.2 Jubilant Pharma Nuclear Medicine Product Overview
  9.8.3 Jubilant Pharma Nuclear Medicine Product Market Performance
  9.8.4 Jubilant Pharma Business Overview
  9.8.5 Jubilant Pharma Recent Developments
9.9 Eli Lilly
  9.9.1 Eli Lilly Nuclear Medicine Basic Information
  9.9.2 Eli Lilly Nuclear Medicine Product Overview
  9.9.3 Eli Lilly Nuclear Medicine Product Market Performance
  9.9.4 Eli Lilly Business Overview
  9.9.5 Eli Lilly Recent Developments
9.10 SIEMENS
  9.10.1 SIEMENS Nuclear Medicine Basic Information
  9.10.2 SIEMENS Nuclear Medicine Product Overview
  9.10.3 SIEMENS Nuclear Medicine Product Market Performance
  9.10.4 SIEMENS Business Overview
  9.10.5 SIEMENS Recent Developments
9.11 China Isotope and Radiation
  9.11.1 China Isotope and Radiation Nuclear Medicine Basic Information
  9.11.2 China Isotope and Radiation Nuclear Medicine Product Overview
  9.11.3 China Isotope and Radiation Nuclear Medicine Product Market Performance
  9.11.4 China Isotope and Radiation Business Overview
  9.11.5 China Isotope and Radiation Recent Developments
9.12 Dongcheng
  9.12.1 Dongcheng Nuclear Medicine Basic Information
  9.12.2 Dongcheng Nuclear Medicine Product Overview
  9.12.3 Dongcheng Nuclear Medicine Product Market Performance
  9.12.4 Dongcheng Business Overview
  9.12.5 Dongcheng Recent Developments

10 NUCLEAR MEDICINE REGIONAL MARKET FORECAST

10.1 Global Nuclear Medicine Market Size Forecast
10.2 Global Nuclear Medicine Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Nuclear Medicine Market Size Forecast by Country
  10.2.3 Asia Pacific Nuclear Medicine Market Size Forecast by Region
  10.2.4 South America Nuclear Medicine Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine by Country

11 MARKET SEGMENTATION & SIZE FORECAST (2023-2028)

11.1 Global Nuclear Medicine Market Forecast by Type (2023-2028)
11.2 Global Nuclear Medicine Market Forecast by Application (2023-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Revenue (M USD) by Manufacturers (2017-2022)
Table 6. Global Nuclear Medicine Revenue Share by Manufacturers (2017-2022)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2021)
Table 8. Manufacturers Nuclear Medicine Sales Sites and Area Served
Table 9. Manufacturers Nuclear Medicine Service Type
Table 10. Global Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Nuclear Medicine
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Nuclear Medicine Market Challenges
Table 18. Market Restraints
Table 19. Global Nuclear Medicine Market Size by Type (M USD)
Table 20. Global Nuclear Medicine Market Size (M USD) by Type (2017-2022)
Table 21. Global Nuclear Medicine Market Size Share by Type (2017-2022)
Table 22. Global Nuclear Medicine Sales Growth Rate by Type (2017-2022)
Table 23. Global Nuclear Medicine Sales (K Units) by Application
Table 24. Global Nuclear Medicine Market Size by Application
Table 25. Global Nuclear Medicine Sales by Application (2017-2022) & (M USD)
Table 26. Global Nuclear Medicine Market Share by Application (2017-2022)
Table 27. Global Nuclear Medicine Sales Growth Rate by Application (2017-2022)
Table 28. Global Nuclear Medicine Market Size by Region (2017-2022) & (M USD)
Table 29. Global Nuclear Medicine Market Share by Region (2017-2022)
Table 30. North America Nuclear Medicine Market Size by Country (2017-2022) & (M USD)
Table 31. Europe Nuclear Medicine Market Size by Country (2017-2022) & (M USD)
Table 32. Asia Pacific Nuclear Medicine Market Size by Region (2017-2022) & (M USD)
Table 33. South America Nuclear Medicine Market Size by Country (2017-2022) & (M USD)
Table 34. Middle East and Africa Nuclear Medicine Market Size by Region (2017-2022) & (M USD)
Table 35. GE Healthcare Nuclear Medicine Basic Information
Table 36. GE Healthcare Nuclear Medicine Product Overview
Table 37. GE Healthcare Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 38. GE Healthcare Business Overview
Table 39. GE Healthcare Nuclear Medicine SWOT Analysis
Table 40. GE Healthcare Recent Developments
Table 41. Bracco Imaging Nuclear Medicine Basic Information
Table 42. Bracco Imaging Nuclear Medicine Product Overview
Table 43. Bracco Imaging Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 44. Bracco Imaging Business Overview
Table 45. Bracco Imaging Nuclear Medicine SWOT Analysis
Table 46. Bracco Imaging Recent Developments
Table 47. Mallinckrodt Nuclear Medicine Basic Information
Table 48. Mallinckrodt Nuclear Medicine Product Overview
Table 49. Mallinckrodt Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 50. Mallinckrodt Business Overview
Table 51. Mallinckrodt Nuclear Medicine SWOT Analysis
Table 52. Mallinckrodt Recent Developments
Table 53. Lantheus Medical Imaging Nuclear Medicine Basic Information
Table 54. Lantheus Medical Imaging Nuclear Medicine Product Overview
Table 55. Lantheus Medical Imaging Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 56. Lantheus Medical Imaging Business Overview
Table 57. Lantheus Medical Imaging Nuclear Medicine SWOT Analysis
Table 58. Lantheus Medical Imaging Recent Developments
Table 59. Bayer Nuclear Medicine Basic Information
Table 60. Bayer Nuclear Medicine Product Overview
Table 61. Bayer Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 62. Bayer Business Overview
Table 63. Bayer Nuclear Medicine SWOT Analysis
Table 64. Bayer Recent Developments
Table 65. Triad Isotopes Nuclear Medicine Basic Information
Table 66. Triad Isotopes Nuclear Medicine Product Overview
Table 67. Triad Isotopes Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 68. Triad Isotopes Business Overview
Table 69. Triad Isotopes Recent Developments
Table 70. Nordion Nuclear Medicine Basic Information
Table 71. Nordion Nuclear Medicine Product Overview
Table 72. Nordion Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 73. Nordion Business Overview
Table 74. Nordion Recent Developments
Table 75. Jubilant Pharma Nuclear Medicine Basic Information
Table 76. Jubilant Pharma Nuclear Medicine Product Overview
Table 77. Jubilant Pharma Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 78. Jubilant Pharma Business Overview
Table 79. Jubilant Pharma Recent Developments
Table 80. Eli Lilly Nuclear Medicine Basic Information
Table 81. Eli Lilly Nuclear Medicine Product Overview
Table 82. Eli Lilly Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Recent Developments
Table 85. SIEMENS Nuclear Medicine Basic Information
Table 86. SIEMENS Nuclear Medicine Product Overview
Table 87. SIEMENS Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 88. SIEMENS Business Overview
Table 89. SIEMENS Recent Developments
Table 90. China Isotope and Radiation Nuclear Medicine Basic Information
Table 91. China Isotope and Radiation Nuclear Medicine Product Overview
Table 92. China Isotope and Radiation Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 93. China Isotope and Radiation Business Overview
Table 94. China Isotope and Radiation Recent Developments
Table 95. Dongcheng Nuclear Medicine Basic Information
Table 96. Dongcheng Nuclear Medicine Product Overview
Table 97. Dongcheng Nuclear Medicine Revenue (M USD) and Gross Margin (2017-2022)
Table 98. Dongcheng Business Overview
Table 99. Dongcheng Recent Developments
Table 100. Global Nuclear Medicine Market Size Forecast by Region (M USD)
Table 101. North America Nuclear Medicine Market Size Forecast by Country (2023-2028) & (M USD)
Table 102. Europe Nuclear Medicine Market Size Forecast by Country (2023-2028) & (M USD)
Table 103. Asia Pacific Nuclear Medicine Market Size Forecast by Region (2023-2028) & (M USD)
Table 104. South America Nuclear Medicine Market Size Forecast by Country (2023-2028) & (M USD)
Table 105. Middle East and Africa Nuclear Medicine Market Size Forecast by Country (2023-2028) & (M USD)
Table 106. Global Nuclear Medicine Market Size Forecast by Type (2023-2028) & (M USD)
Table 107. Global Nuclear Medicine Market Size Forecast by Application (2023-2028) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Nuclear Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Market Size (M USD), 2017-2028
Figure 5. Global Nuclear Medicine Market Size (M USD) (2017-2028)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Nuclear Medicine Market Size (M USD) by Country (M USD)
Figure 10. Global Nuclear Medicine Revenue Share by Manufacturers in 2021
Figure 11. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 12. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Revenue in 2021
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Nuclear Medicine Market Share by Type
Figure 15. Market Size Share of Nuclear Medicine by Type (2017-2022)
Figure 16. Market Size Market Share of Nuclear Medicine by Type in 2021
Figure 17. Global Nuclear Medicine Sales Growth Rate by Type (2017-2022)
Figure 18. Global Nuclear Medicine Market Share by Application
Figure 19. Global Nuclear Medicine Market Share by Application (2017-2022)
Figure 20. Global Nuclear Medicine Market Share by Application in 2021
Figure 21. Global Nuclear Medicine Sales Growth Rate by Application (2017-2022)
Figure 22. Global Nuclear Medicine Market Share by Region (2017-2022)
Figure 23. North America Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 24. North America Nuclear Medicine Market Share by Country in 2021
Figure 25. U.S. Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 26. Canada Nuclear Medicine Market Size (M USD) and Growth Rate (2017-2022)
Figure 27. Mexico Nuclear Medicine Market Size (Units) and Growth Rate (2017-2022)
Figure 28. Europe Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 29. Europe Nuclear Medicine Market Share by Country in 2021
Figure 30. Germany Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 31. France Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 32. U.K. Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 33. Italy Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 34. Russia Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 35. Asia Pacific Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 36. Asia Pacific Nuclear Medicine Market Share by Region in 2021
Figure 37. China Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 38. Japan Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 39. South Korea Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 40. India Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 41. Southeast Asia Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 42. South America Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 43. South America Nuclear Medicine Market Share by Country in 2021
Figure 44. Brazil Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 45. Argentina Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 46. Columbia Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 47. Middle East and Africa Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 48. Middle East and Africa Nuclear Medicine Market Share by Region in 2021
Figure 49. Saudi Arabia Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 50. UAE Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 51. Egypt Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 52. Nigeria Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 53. South Africa Nuclear Medicine Market Size and Growth Rate (2017-2022) & (M USD)
Figure 54. Global Nuclear Medicine Market Size Forecast by Value (2017-2028) & (M USD)
Figure 55. Global Nuclear Medicine Market Share Forecast by Type (2023-2028)
Figure 56. Global Nuclear Medicine Market Share Forecast by Application (2023-2028)